Literature DB >> 8056812

A quantitative model of invasive Pseudomonas infection in burn injury.

E J Stevens1, C M Ryan, J S Friedberg, R L Barnhill, M L Yarmush, R G Tompkins.   

Abstract

To evaluate newer therapies for wound infections, it becomes necessary to quantify bacteria that invade from the infected wounds into the adjacent tissues. For example, antibody-targeted photolysis targets the invasive Pseudomonas with antibodies carrying photochemical dyes. A full-thickness burn wound was infected with Pseudomonas aeruginosa with a modification of previous methods. In mice, a skin fold was elevated, and two preheated brass blocks at 92 degrees to 95 degrees C were applied for 5 seconds, producing a 5% total body surface area injury with discrete margins. The eschars were immediately inoculated with Pseudomonas. Survival at 10 days was 100% with burn injury alone and 60% with infected burns. Pseudomonas (10(8)/gm) were recovered from the unburned muscle by 24 hours. The method produced uniform and reproducible quantitative bacteriology within the muscle immediately beneath the burn injury (SL < 0.05). Quantitative comparisons can be used to determine the effectiveness of newer modalities to control Pseudomonas burn wound infections.

Entities:  

Mesh:

Year:  1994        PMID: 8056812     DOI: 10.1097/00004630-199405000-00005

Source DB:  PubMed          Journal:  J Burn Care Rehabil        ISSN: 0273-8481


  29 in total

1.  Pseudomonas aeruginosa OxyR is required for full virulence in rodent and insect models of infection and for resistance to human neutrophils.

Authors:  Gee W Lau; Bradley E Britigan; Daniel J Hassett
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

2.  Passive immunization to outer membrane proteins MLP and PAL does not protect mice from sepsis.

Authors:  Catherine H Valentine; Judith Hellman; Laura K Beasley-Topliffe; Aranya Bagchi; H Shaw Warren
Journal:  Mol Med       Date:  2006 Sep-Oct       Impact factor: 6.354

3.  Development of an experimental model of infected skin ulcer.

Authors:  Masahiro Tachi; Shinichi Hirabayashi; Yoshiyuki Yonehara; Yasutoshi Suzuki; Philip Bowler
Journal:  Int Wound J       Date:  2004-04       Impact factor: 3.315

Review 4.  Topical antimicrobials for burn infections - an update.

Authors:  Mert Sevgi; Ani Toklu; Daniela Vecchio; Michael R Hamblin
Journal:  Recent Pat Antiinfect Drug Discov       Date:  2013-12

5.  Identification of virulence genes in a pathogenic strain of Pseudomonas aeruginosa by representational difference analysis.

Authors:  Ji Young Choi; Costi D Sifri; Boyan C Goumnerov; Laurence G Rahme; Frederick M Ausubel; Stephen B Calderwood
Journal:  J Bacteriol       Date:  2002-02       Impact factor: 3.490

6.  Photodynamic therapy for Acinetobacter baumannii burn infections in mice.

Authors:  Tianhong Dai; George P Tegos; Zongshun Lu; Liyi Huang; Timur Zhiyentayev; Michael J Franklin; David G Baer; Michael R Hamblin
Journal:  Antimicrob Agents Chemother       Date:  2009-06-29       Impact factor: 5.191

7.  Killing of Caenorhabditis elegans by Pseudomonas aeruginosa used to model mammalian bacterial pathogenesis.

Authors:  M W Tan; S Mahajan-Miklos; F M Ausubel
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

Review 8.  Natural pathogens of laboratory mice, rats, and rabbits and their effects on research.

Authors:  D G Baker
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

9.  Differential roles of the Pseudomonas aeruginosa PA14 rpoN gene in pathogenicity in plants, nematodes, insects, and mice.

Authors:  E L Hendrickson; J Plotnikova; S Mahajan-Miklos; L G Rahme; F M Ausubel
Journal:  J Bacteriol       Date:  2001-12       Impact factor: 3.490

10.  The pathogenic properties of a novel and conserved gene product, KerV, in proteobacteria.

Authors:  Dingding An; Yiorgos Apidianakis; Ana Laura Boechat; Regina L Baldini; Boyan C Goumnerov; Laurence G Rahme
Journal:  PLoS One       Date:  2009-09-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.